$MYDX Finding a Chemical Profile that Works for Yo
Post# of 2218
(Total Views: 236)
Posted On: 04/17/2017 5:58:02 PM
$MYDX Finding a Chemical Profile that Works for You
In a recent article referenced in Forbes entitled Cannabis Lab Testing Is The Industry's Dirty Little Secret, the challenge of testing, tracking and finding the right chemical profile to meet a patient’s needs becomes even more compounded when one faces the reality that not all labs are created equal, and even if they were, not all branded samples named ‘Blue Dream’ have similar chemical profiles. This creates a serious problem when people think they are buying a consistent cannabis product based on its name, which at this point in the developing market, means very little.
"We are finally getting to heart of what aliments people are tracking and more importantly, what unique chemicals profiles are helping them find relief”, stated Daniel Yazbeck, Chief Executive Officer of MyDx. “By mining this HIPPA Compliant Data, we are now identifying the specific 'green Active Pharmaceutical Ingredients' (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs”.
As more data is accumulated and as formulations become validated, MyDx intends to commercialize those remedies and have them more readily available for mass consumption.
In a recent article referenced in Forbes entitled Cannabis Lab Testing Is The Industry's Dirty Little Secret, the challenge of testing, tracking and finding the right chemical profile to meet a patient’s needs becomes even more compounded when one faces the reality that not all labs are created equal, and even if they were, not all branded samples named ‘Blue Dream’ have similar chemical profiles. This creates a serious problem when people think they are buying a consistent cannabis product based on its name, which at this point in the developing market, means very little.
"We are finally getting to heart of what aliments people are tracking and more importantly, what unique chemicals profiles are helping them find relief”, stated Daniel Yazbeck, Chief Executive Officer of MyDx. “By mining this HIPPA Compliant Data, we are now identifying the specific 'green Active Pharmaceutical Ingredients' (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs”.
As more data is accumulated and as formulations become validated, MyDx intends to commercialize those remedies and have them more readily available for mass consumption.
(0)
(0)Scroll down for more posts ▼